Figure 1From: Reduction of the HIV-1 reservoir in resting CD4+ T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept studyEffect of intravenous immunoglobulin (IVIG) on resting CD4+ T-cells, plasma HIV-1 RNA, and serum IL-7. Changes in infectious units per million (IUPM) resting CD4+ T-cells, plasma HIV-1 RNA, and serum interleukin-7 (IL-7) levels after addition of high-dose IVIG to continuing antiretroviral treatment. Panel A shows the five subjects with an achieved decrease of replication-competent virus in the latent reservoir. No positive effect was found in the two subjects in panel B.Back to article page